|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.530 HKD | 0.00% |
|
+8.12% | -44.27% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 790.8 | - | - |
| Change | - | -30.05% | -30.06% | -46.66% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 859.5 | 790.8 | 629.1 |
| Change | - | -16.83% | -28.53% | -41.48% | -7.99% | -20.45% |
| P/E | -1.04x | -4.72x | -3.96x | -4.75x | 16.7x | 2.1x |
| PBR | 2.25x | 2.17x | 1.52x | 1.72x | 1.56x | 1.13x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 1.22x | 0.67x | 0.45x |
| EV / Revenue | 18x | 7.35x | 4.37x | 1.33x | 0.67x | 0.36x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -7.23x | 9.7x | 1.42x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -6x | 15x | 2.58x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -2.8x | -28x | 10.2x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -35.7% | -3.57% | 9.8% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 2.176 | 2.176 | 2.176 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 363,368 | - | - |
| Announcement Date | 27/03/24 | 24/03/25 | 24/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.75x | 1.33x | -7.23x | - | 117M | |
| 33.6x | 12.29x | 24.81x | 0.58% | 1,057B | |
| 28.84x | - | - | 2.07% | 625B | |
| 32.34x | 7.35x | 15.3x | 2.81% | 435B | |
| 20.47x | 4.85x | 12.02x | 2.72% | 363B | |
| 22.14x | 5.72x | 14.28x | 2.8% | 296B | |
| 20.58x | 4.25x | 12.07x | 2.07% | 249B | |
| 25.76x | 6.79x | 12.06x | 2.45% | 222B | |
| 13.84x | 4.97x | 10.44x | 3.68% | 209B | |
| -41.38x | 5.93x | 33.46x | 2.47% | 165B | |
| Average | 15.14x | 5.94x | 14.13x | 2.41% | 362.09B | |
| Weighted average by Cap. | 24.44x | 8.09x | 18.31x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
